![COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/social-media/mm7011e2_COVID19VaccineDose2_IMAGE_12Mar21_v4_1200x675.jpg)
COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR
![emDOCs.net – Emergency Medicine EducationPush-Dose Vasopressors: An Update for 2019 - emDOCs.net - Emergency Medicine Education emDOCs.net – Emergency Medicine EducationPush-Dose Vasopressors: An Update for 2019 - emDOCs.net - Emergency Medicine Education](http://www.emdocs.net/wp-content/uploads/2019/04/Screen-Shot-2019-04-21-at-5.23.21-PM.png)
emDOCs.net – Emergency Medicine EducationPush-Dose Vasopressors: An Update for 2019 - emDOCs.net - Emergency Medicine Education
![What is the optimal initial dose of epinephrine during neonatal resuscitation in the delivery room? | Journal of Perinatology What is the optimal initial dose of epinephrine during neonatal resuscitation in the delivery room? | Journal of Perinatology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41372-021-01032-7/MediaObjects/41372_2021_1032_Fig1_HTML.png)
What is the optimal initial dose of epinephrine during neonatal resuscitation in the delivery room? | Journal of Perinatology
![Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials - Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials -](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/9dffa94a-4098-4902-bf61-ec9a648d6467/gr1.jpg)